Blog

August 14, 2026

Webinar Recap | Care Interrupted: How Insurance Barriers Impact Patients

Missed the webinar or want to share it with a colleague, caregiver, or advocate? Watch the full recording here. On…

August 11, 2026

New HRSA Model Will Increase Transparency in 340B Program

CCPA has long advocated for thoughtful reforms to strengthen the 340B Drug Pricing Program. Earlier this year, CCPA submitted comments…

August 6, 2026

Helping Patients Navigate Direct-to-Patient Prescription Platforms

For patients living with chronic and rare conditions, consistent access to prescription medicines is not optional. It is critical to…

August 4, 2026

National Survey Finds Overwhelming Voter Support for Increasing Access to Obesity Medicines

(SACRAMENTO, CA) – The Chronic Care Policy Alliance (CCPA) announced today that a recent national survey showed strong, bipartisan support for increasing access to FDA-approved obesity medicines. Commissioned by CCPA, the Morning Consult survey of 2,001 registered voters nationwide also found…

July 9, 2026

CCPA Submits Comments to FDA on Peptide Compounding

CCPA Submits Comments to FDA on Peptide Compounding The Chronic Care Policy Alliance (CCPA) submitted comments to the FDA’s Pharmacy…

June 16, 2026

CCPA Submits Comment Letter to CMS on Proposed Interoperability Standards and Prior Authorization for Drugs rule

On June 15, 2026, Chronic Care Policy Alliance (CCPA) submitted comments to the Centers for Medicare & Medicaid Services (CMS)…

June 9, 2026

Denied — but Not Defeated: Appeals Help Patients Access Care

Many patients know the sinking feeling when they learn a prescription, a specialist visit, a diagnostic test, or an ongoing…

June 8, 2026

Energy, Insight, and Inspiration: Inside Forecast 2026

Forecast 2026 brought together advocates, health policy experts, health care professionals, and community partners from across the country in San…

May 15, 2026

CCPA Sends Comments to Congress on the Dangers of MFN Pricing Models

The Chronic Care Policy Alliance (CCPA) recently submitted letters to Senate leadership, the Senate HELP and Finance Committees, as well…

April 22, 2026

CCPA Statement on Most Favored Nation

Liz Helms, CEO of the Chronic Care Policy Alliance (CCPA), issued the following statement on Most Favored Nation pricing: “Most Favored Nation…

April 20, 2026

Webinar Recap: Drug Pricing Reform: What Patients Need to Know

On April 9, 2026, CCPA hosted “Drug Pricing Reform: What Patients Need to Know,” a webinar moderated by CCPA CEO…

April 2, 2026

The Mass Compounded GLP-1 Market Is Harming Patients.

For people living with the chronic disease of obesity, GLP-1 medications have been life-changing. Research shows that sustained use reduces…

March 6, 2026

Put Patients First by Studying the 340B Program

Established by Congress in 1992, the 340B Drug Pricing Program was intended to help safety-net providers improve access to healthcare for low-income,…

March 3, 2026

CCPA Submits Comments on IPAY 2028 Selections

On March 1, 2026, Chronic Care Policy Alliance (CCPA) submitted formal comments to the Centers for Medicare & Medicaid Services…